TCL Archive NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening November 5, 2010
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says. May 20, 2005